Tuoxin Pharmaceutical Group Co (SZSE:301089) Days Sales Outstanding : 107.68 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tuoxin Pharmaceutical Group Co Days Sales Outstanding?

Tuoxin Pharmaceutical Group Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥127.8 Mil. Tuoxin Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2024 was ¥108.3 Mil. Hence, Tuoxin Pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 107.68.

The historical rank and industry rank for Tuoxin Pharmaceutical Group Co's Days Sales Outstanding or its related term are showing as below:

SZSE:301089' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.09 Med: 46.9 Max: 162.33
Current: 162.33

During the past 10 years, Tuoxin Pharmaceutical Group Co's highest Days Sales Outstanding was 162.33. The lowest was 22.09. And the median was 46.90.

SZSE:301089's Days Sales Outstanding is ranked worse than
91.89% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs SZSE:301089: 162.33

Tuoxin Pharmaceutical Group Co's Days Sales Outstanding increased from Mar. 2023 (20.67) to Mar. 2024 (107.68).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Tuoxin Pharmaceutical Group Co Days Sales Outstanding Historical Data

The historical data trend for Tuoxin Pharmaceutical Group Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tuoxin Pharmaceutical Group Co Days Sales Outstanding Chart

Tuoxin Pharmaceutical Group Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

39.17

22.09

34.42

23.13

42.31

Tuoxin Pharmaceutical Group Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															20.67	181.00	209.95	178.24	107.68

Competitive Comparison of Tuoxin Pharmaceutical Group Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Tuoxin Pharmaceutical Group Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tuoxin Pharmaceutical Group Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tuoxin Pharmaceutical Group Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Tuoxin Pharmaceutical Group Co's Days Sales Outstanding falls into.

Tuoxin Pharmaceutical Group Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Tuoxin Pharmaceutical Group Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (42.042	+	151.678)	/	2 )	/	835.51	*	365
=	96.86					/	835.51	*	365
=	42.31

Tuoxin Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (151.678	+	103.974)	/	2 )	/	108.323	*	365 / 4
=	127.826					/	108.323	*	365 / 4
=	107.68

Tuoxin Pharmaceutical Group Co (SZSE:301089) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Tuoxin Pharmaceutical Group Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Tuoxin Pharmaceutical Group Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Tuoxin Pharmaceutical Group Co (SZSE:301089) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tuoxin Pharmaceutical Group Co Ltd (SZSE:301089) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 398, Jingquan West Road, High-tech Zone, Henan Province, Xinxiang, CHN, 453000

Website

http://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co Ltd, formerly Xinxiang Tuoxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical synthesis and biological fermentation nucleoside APIs and pharmaceutical intermediates.

Tuoxin Pharmaceutical Group Co (SZSE:301089) Headlines

No Headlines